CXCL13 and neoplasm: Several of these chemokines including CCL21 (~224-fold) and CXCL13 (~66-fold) were previously shown to exert immunosuppressive effects by recruiting CD4 and CD8 T cells and DC in the TME, thereby inhibiting tumor progression and metastasis [47].